Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.

[1]  M. Kikuchi,et al.  Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies. , 1982, The Biochemical journal.

[2]  G. Torri,et al.  The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. , 1981, The Biochemical journal.

[3]  J. Fareed,et al.  STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN , 1981, Annals of the New York Academy of Sciences.

[4]  M. Höök,et al.  The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups. , 1981, The Journal of biological chemistry.

[5]  K. Kurachi,et al.  The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. , 1981, The Biochemical journal.

[6]  U. Lindahl,et al.  The molecular size of the antithrombin‐binding sequence in heparin , 1980, FEBS letters.

[7]  G. Torri,et al.  Anti-Xa active heparin oligosaccharides. , 1980, Thrombosis research.

[8]  U. Lindahl,et al.  On the molecular-weight-dependence of the anticoagulant activity of heparin. , 1979, The Biochemical journal.

[9]  M. Höök,et al.  The molecular-weight-dependence of the anti-coagulant activity of heparin. , 1978, The Biochemical journal.

[10]  M. L. Larsen,et al.  Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238). , 1978, Thrombosis research.

[11]  M. Lie,et al.  Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. , 1977, Thrombosis research.

[12]  R. Einarsson,et al.  Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. , 1977, Biochimica et biophysica acta.

[13]  E. Thaler,et al.  A Simple Two‐step Isolation Procedure for Human and Bovine Antithrombin II/III (Heparin Cofactor): a Comparison of Two Methods , 1975, British journal of haematology.

[14]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[15]  S. Wessler,et al.  Plasma heparin: a unique, practical, submicrogram-sensitive assay. , 1973, The Journal of laboratory and clinical medicine.

[16]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[17]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.

[18]  E. A. Johnson,et al.  Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. , 1979, Thrombosis research.